Leverone Jason A.

CIK 00016927472 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001692747

Recent Transactions

20 trades

Sale
OnKure Therapeutics, Inc.$OKUR
Class A Common Stock
2025-09-22$2.62/sh−303→ 12,603 total
Sale
OnKure Therapeutics, Inc.$OKUR
Class A Common Stock
2025-06-23$2.38/sh−303→ 12,906 total
Sale
OnKure Therapeutics, Inc.$OKUR
Class A Common Stock
2025-04-07$2.67/sh−1,844→ 13,209 total
Sale
OnKure Therapeutics, Inc.$OKUR
Class A Common Stock
2025-04-04$3.33/sh−1,278→ 15,053 total
Award
OnKure Therapeutics, Inc.$OKUR
Employee Stock Option (right to buy)
2025-01-27+65,000→ 65,000 total
Award
OnKure Therapeutics, Inc.$OKUR
Class A Common Stock
2024-10-04+16,331→ 16,331 total
Award
OnKure Therapeutics, Inc.$OKUR
Employee Stock Option (right to buy)
2024-10-04+5,781→ 5,781 total
Award
OnKure Therapeutics, Inc.$OKUR
Employee Stock Option (right to buy)
2024-10-04+5,322→ 5,322 total
Award
OnKure Therapeutics, Inc.$OKUR
Employee Stock Option (right to buy)
2024-10-04+130,611→ 130,611 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Employee Stock Option (right to buy)
2021-01-18+311,785→ 311,785 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2020-03-13$0.57/sh+11,249→ 48,829 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2020-03-13−11,249→ 0 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2020-02-12+185,000→ 185,000 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2019-08-23$0.57/sh+3,093→ 36,330 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2019-08-23−3,093→ 0 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2019-02-06+75,000→ 75,000 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2018-08-07−29,530→ 0 total
Exercise/Conversion
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2018-08-07$0.57/sh+29,530→ 30,737 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2018-01-31+75,000→ 75,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2017-02-16+77,500→ 77,500 total

Companies

Recent Filings

Address

C/O ONKURE THEREAPEUTICS, INC. 6707 WINCHESTER CIRCLE, SUITE 400

BOULDER, CO, 80301

View on SEC.gov